Header Logo

Connection

MONICA CHEN to National Cancer Institute (U.S.)

Back to Details
This is a "connection" page, showing publications MONICA CHEN has written about National Cancer Institute (U.S.).
MONICA CHEN
Connection Strength
0.210
National Cancer Institute (U.S.)
  1. Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E. JCO Precis Oncol. 2024 04; 8:e2300454.
    View in: PubMed
    Score: 0.210
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.